Active Ingredient History

  • Now
Acetohydroxamic acid (also known as AHA or by the trade name Lithostat) is a synthetic drug derived from hydroxylamine and ethyl acetate, is similar in structure to urea. In the urine, it acts as an antagonist of the bacterial enzyme urease. Acetohydroxamic acid is used to lower the level of ammonia in the urine, which may help with some types of urinary infections. Acetohydroxamic Acid has no direct antimicrobial action and does not acidify urine directly. It is used, in addition to antibiotics or medical procedures, to treat chronic urea-splitting urinary infections. In 1983 the US Food and Drug Administration approved acetohydroxamic acid (AHA) as an orphan drug for "prevention of so-called struvite stones" under the newly enacted Orphan Drug Act of 1983.   NCATS

  • Mol. Mass: 75.0666
  • ALogP: -0.49
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

acethydroxamsaeure | acethydroxamsaure | acetic acid, oxime | acetohydroxamate | acetohydroxamic acid | acetohydroximic acid | acetylhydroxamic acid | acetyl hydroxyamino | acide acetohydroxamique | acido acetohidroxamico | acidum acetohydroxamicum | aha | cetohyroxamic acid | lithostat | methylhydroxamic acid | mission brand of acetohydroxamic acid | n-acetyl hydroxyacetamide | n-acetylhydroxylamine | n-hydroxyacetamide | n-hydroxyacetamidine | robert brand of acetohydroxamic acid | uronefrex


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue